Medha Dyechem Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 24-12-2024
- Paid Up Capital ₹ 3.91 Cr
as on 24-12-2024
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.94 M
as on 24-12-2024
- Revenue 4.75%
(FY 2020)
- Profit -27.23%
(FY 2020)
- Ebitda -12.17%
(FY 2020)
- Net Worth 7.61%
(FY 2020)
- Total Assets 1.58%
(FY 2020)
About Medha Dyechem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.91 Cr.
The company currently has active open charges totaling ₹3.94 M.
Giridhar Thota and Shobha Thota serve as directors at the Company.
- CIN/LLPIN
U24239TG1993PTC016807
- Company No.
016807
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medha Dyechem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Giridhar Thota  | Director | 05-Sep-2003 | Current |
| Shobha Thota | Director | 17-Feb-2005 | Current |
Financial Performance of Medha Dyechem.
Medha Dyechem Pvt Ltd, for the financial year ended 2020, experienced modest growth in revenue, with a 4.75% increase. The company also saw a substantial fall in profitability, with a 27.23% decrease in profit. The company's net worth moved up by a moderate rise of 7.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medha Dyechem?
In 2018, Medha Dyechem had a promoter holding of 98.46% and a public holding of 1.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spica Laboratories Private LimitedActive 19 years 10 monthsGiridhar Thota and Shobha Thota are mutual person
Sahasra Laboratories Private LimitedActive 18 years 7 monthsGiridhar Thota and Shobha Thota are mutual person
- Syngen Laboratories Private LimitedActive 20 years 11 months
Giridhar Thota and Shobha Thota are mutual person
- Sheetal Chemicals Private LimitedActive 20 years 5 months
Giridhar Thota and Shobha Thota are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 Oct 1995 | ₹3.00 M | Open |
Ap State Financial Corporation Creation Date: 30 Mar 1994 | ₹0.94 M | Open |
How Many Employees Work at Medha Dyechem?
Medha Dyechem has a workforce of 10 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medha Dyechem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medha Dyechem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
